647 related articles for article (PubMed ID: 25589779)
21. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
Magdalinou NK; Noyce AJ; Pinto R; Lindstrom E; Holmén-Larsson J; Holtta M; Blennow K; Morris HR; Skillbäck T; Warner TT; Lees AJ; Pike I; Ward M; Zetterberg H; Gobom J
Parkinsonism Relat Disord; 2017 Apr; 37():65-71. PubMed ID: 28214264
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
[TBL] [Abstract][Full Text] [Related]
24. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
[TBL] [Abstract][Full Text] [Related]
26. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
[TBL] [Abstract][Full Text] [Related]
28. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
Hall S; Janelidze S; Surova Y; Widner H; Zetterberg H; Hansson O
Sci Rep; 2018 Sep; 8(1):13276. PubMed ID: 30185816
[TBL] [Abstract][Full Text] [Related]
31. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson's disease.
Xiang C; Cong S; Tan X; Ma S; Liu Y; Wang H; Cong S
NPJ Parkinsons Dis; 2022 Nov; 8(1):165. PubMed ID: 36446820
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes.
Starhof C; Winge K; Heegaard NHH; Skogstrand K; Friis S; Hejl A
J Neuroinflammation; 2018 Nov; 15(1):305. PubMed ID: 30390673
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
Holmberg B; Johnels B; Blennow K; Rosengren L
Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
[TBL] [Abstract][Full Text] [Related]
35. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
[TBL] [Abstract][Full Text] [Related]
36. Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders.
Zhu S; Bäckström D; Forsgren L; Trupp M
J Parkinsons Dis; 2022; 12(4):1169-1189. PubMed ID: 35253777
[TBL] [Abstract][Full Text] [Related]
37. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
Bäckström DC; Eriksson Domellöf M; Linder J; Olsson B; Öhrfelt A; Trupp M; Zetterberg H; Blennow K; Forsgren L
JAMA Neurol; 2015 Oct; 72(10):1175-82. PubMed ID: 26258692
[TBL] [Abstract][Full Text] [Related]
40. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
